In parallel, there is growing focus on small molecule GLP-1R agonists , which have the potential to be administered orally, produced more cost-effectively, and offer improved stability and pharmacokinetic profiles
Cohort 25 adult participants Trial design Randomised crossover design Markers GLP-1, glucose, insulin & appetite Published in Journal of Obesity Weight Loss Therapy Supports healthier post-meal glucose balance ~8% Lower glucose rise at 60 mins ~9.7% Reduction at 90 mins Lower Post-meal glucose excursions observed overall A sharper spike vs
These significant CV events were assessed regardless of change in weight in the landmark SELECT trial," the company said in a statement
If there are no GI symptoms but the drug was not DCd as suggested, treat as full stomach, evaluate contents with ultrasound, and consider delaying the procedure
Adhering to these tips is much easier when GLP-1 medication lowers appetite